If you need more lookups,
subscriptions start at $34 USD/month.
Gregory Gorgas Location
Encinitas, CA, US
Gregory Gorgas Work
2017 -now President and CEO @
2009 -2019 Founder and Director @ Theragence, Inc.
2011 -2016 Senior Vice President, Commercial @ Mast Therapeutics, Inc.
1997 -2008 Sr. Director, Marketing @
1990 -1997 Sales Management and Corporate Accounts @ Chiron Corporation
Gregory Gorgas Education
University of Phoenix
MBA
1995-1997
California State University, Northridge
BA (Economics)
1981-1986
Gregory Gorgas Skills
Sales Management
Negotiation
Marketing
Business Development
Sales
Supply Chain
Biotechnology
Commercialization
Medical Affairs
Pharmaceutical Industry
Oncology
Neurology
Managed Care
Strategy
Hospital Sales
FDA
Lifesciences
Infectious Diseases
Hematology
Pharmaceutical Sales
Product Launch
Drug Development
Therapeutic Areas
Biopharmaceuticals
Cross-functional Team Leadership
Start-ups
Medical Devices
Leadership
Contract Negotiation
Entrepreneurship
Clinical Development
Clinical Trials
Global Marketing
Regulatory Affairs
Technology Transfer
Vaccines
CRO
Drug Discovery
Hardware Diagnostics
Regulatory Submissions
Pharmaceutics
Biotechnology Industry
Market Access
Commercial Business Development
Product Lifecycle Management
Life Sciences
U.S. Food and Drug Administration (FDA)
Cross Functional Team Leadership
Start Ups
Account Management
Strategic Planning
u.s. Food and Drug Administration Fda
u.s. Food and Drug Administration
Gregory Gorgas Summary
Gregory Gorgas, based in Encinitas, CA, US, is currently a President and CEO at Artelo Biosciences, Inc.. Gregory Gorgas brings experience from previous roles at Theragence, Inc., Mast Therapeutics, Inc., Biogen Idec and Chiron Corporation. Gregory Gorgas holds a 1995 - 1997 MBA @ University of Phoenix. With a robust skill set that includes Sales Management, Negotiation, Marketing, Business Development, Sales and more. Gregory Gorgas has 4 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Gregory Gorgas?
Find contact details for 700 million professionals.